B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia and lymphoma.
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia, lymphoma and rheumatoid arthritis. 3D rendering based on protein data bank entry 2osl. Combined cartoon and stick representation with backbone gradient coloring (rituximab). CD20 epitope colored magenta. Background black.
Size: 8000px × 6000px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No
Keywords: -cell, -lymphocyte, 20, 3d, acid, amino, antibody, antigen, arthritis, atoms, autoimmune, cancer, cd, cd20, cluster, differentiation, disease, epitope, fab, health, histology, illustration, immunohistochemistry, leukemia, lymphocyte, lymphoma, model, molecular, molecule, monoclonal, ms4a1, pdb_2osl, pemphigus, peptide, polymer, polypeptide, protein, purpura, rendering, rheumatoid, rituximab, science, scientific, structure, surface, thrombocytopenic, vulgaris
